By building an innovation incubation platform and technology promotion platform with the shared resources and services in medical device industry, to develop into an open, integrated and sustainable innovation ecosystem of medical devices industry, establish medical academic support system, promote the coordinated development of industry, enhance the academic position and international influence of domestic medical research institutions in the related field, and make contributions to the development of the medical device industry in China.

For the purpose of filling in the domestic market gap and introducing world leading technology, MED·Circle Group discovers, invests and integrates medical projects with disruptive innovation technologies in the industry around the world, and is committed to seeking effective treatment solutions for major illnesses diseases that threaten people's health seriously and lack of effective therapy in clinic.

MED·Circle Group has established an intelligent event management system platform of independent research and development with a targeted database for more than 1 million doctors and 500,000 medical professionals. Through onsite service and online promotion of medical academic events, medical data management and analysis, we provide efficient digital marketing integration services for the government, associations, societies and pharmaceutical enterprises. With the large-scale academic support team, top international medical consultant team (from the domestic and foreign famous clinicians and experts), and rich experience in the industry, MED·Circle Group has realized the localization and industrialization of the global innovative medical technology in China, driven by independent innovation and secondary innovation based on imported technologies.

With the associated professional venture capital fund - Xin Zhaoyuan Capital Management Co., Ltd., MED·Circle Group takes full advantage of capital, resources and industry experience to incubate domestic early-stage innovative life science and technology projects, accelerates their growth and industrialization. Meanwhile, we introduce foreign top medical science and technology projects with venture capital funds, and achieve the localization of technology by secondary innovation based on imported technologies. We focus on the innovative treatment technologies, including cardiovascular and cerebrovascular, neurovascular, oncotherapy, AI and Robotic Care.

A joint venture platform which covering nearly 10,000 square meters, for supporting medical device innovation and transformation established by MED·Circle Group and Shanghai Zhangjiang Group in Shanghai, under Medical Device Research Institute, Testing Center, Patent Service Center, CRO&CDMO Service Center, Industrial Landing Service Center, and R&D Center. MED·Circle Group will takes full advantage of the policy for Marketing Authorization Holder (MAH) , to not only provide R&D outsourcing services including GMP workshop and product validation testing services, but provide the value-added services involving patent application, animal experiment, design verification, application to NMPA and academic market promotion to project developers.

null